By Bisola Adeyemo
The use of Oxford/AstraZeneca COVID-19 vaccine in Nigeria has been officially accepted by the National Agency for Food, Drug Administration and Control, (NAFDAC).
NAFDAC Director-General, Dr. Mojisola Adeyeye disclosed this while briefing journalists on Thursday, in Abuja.
Related Posts
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 to-19, or AZD1222, is a viral vector vaccine, which was recently approved by the World Health Organisation, WHO. It can be stored at 2 to 8-degree centigrade. According to her
However, the NAFDAC boss said the body got the dossier of the vaccine a week ago and its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
She said there are additional three vaccines undergoing evaluation, but the evaluation on Astrazeneca indicates that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.
Dr. Adeyeye disclosed that the South African new variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.
